Female Breast Carcinoma Clinical Trial
Official title:
Effect of Yoga on Life Quality and Immunity in Breast Cancer Patients After Operation and or Chemotherapy
The purpose of study is to investigate if yoga exercise improve life quality and immune status in breast cancer patients after complete treatment (including surgery and / or radiotherapy and / or chemotherapy)
It is well-known that exercise promote immune regulation for better life quality. However,
the mechanism for better immunity and life quality is not clear. We postulate that Ayurveda
yoga might benefit breast cancer women with completion of operation and/or chemotherapy and
radiotherapy. The benefits could be due to immune modulation, and improve health perception
and life quality, and even potential decrease of cancer relapse.
The study patients will do yoga twice a week for 12 weeks. The study primary endpoints are
1) to improve personal health perception, 2) to improve life quality and 3) to enhance human
immunity. The study secondary endpoint will follow up the immunity changes 3 months after
the intervention.
We anticipate to reach the primary endpoints and to publish the primary results in one year,
the secondary endpoint will complete in the second year.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04290585 -
Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for Mammography
|
N/A | |
Terminated |
NCT02540330 -
A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant
|
Phase 2 | |
Completed |
NCT02005770 -
Anesthesia and Circulating Tumor Cells in Breast Cancer
|
Phase 4 | |
Completed |
NCT01643148 -
The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast Cancer
|
N/A | |
Active, not recruiting |
NCT02942355 -
Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer
|
Phase 2 |